| View |
|
DR-XY41278
|
Fluphenazine Decanoate
|
Psycosin
|
25 mg/mL
|
Solution For Injection
|
Antipsychotic (Phenothiazine with piperazine structure)
|
Swiss Parenterals Pvt. Ltd.
|
India
|
Automatic Renewal
|
30 August 2022
|
28 September 2027
|
| View |
|
DR-XY41287
|
Hypromellose
|
Equisine Moist
|
30mg
|
Ophthalmic Drops
|
Ophthalmologic Lubricant
|
Duopharma Trade Philippines Inc.
|
Philippines
|
Automatic Renewal
|
26 July 2022
|
03 October 2027
|
| View |
|
DR-XY41289
|
Tranexamic Acid
|
Suprehem
|
500 mg
|
Capsule
|
Antifibrinolytic
|
Flamingo Pharmaceuticals Ltd.
|
India
|
Automatic Renewal
|
18 July 2022
|
02 October 2027
|
| View |
|
DR-XY41290
|
Paracetamol + Phenylephrine Hydrochloride + Chlorphenamine Maleate
|
Sinuplus
|
500 mg/10 mg/2 mg
|
Film-Coated Tablet
|
Analgesic-Antipyretic/ Nasal Decongestant/ Antihistamine
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
08 July 2022
|
02 October 2027
|
| View |
DR-XY41291_PI_01.pdf
|
DR-XY41291
|
Amlodipine (As Besilate)
|
SITIvax
|
10 mg
|
Tablet
|
CALCIUM CHANNEL BLOCKER
|
Zest Pharma
|
India
|
Automatic Renewal
|
08 July 2022
|
02 October 2027
|
| View |
|
DR-XY41292
|
Doxorubicin Hydrochloride
|
Lipo-Dox
|
2mg/mL
|
Solution For Injection
|
Antineoplastic ( Anthracycline)
|
TTY Biopharm Company Limited Li Factory
|
Taiwan
|
Automatic Renewal
|
12 February 2022
|
23 October 2027
|
| View |
|
DR-XY41300
|
Polymyxin B Sulfate + Bacitracin Zinc + Neomycin Sulfate
|
None
|
710 mcg/10 mg/5 mg
|
Topical Ointment
|
Antibacterial
|
Llyod Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
28 September 2022
|
03 October 2027
|
| View |
|
DR-XY41307
|
Degarelix
|
Firmagon
|
120 mg
|
Freeze-dried Powder for Solution for Injection
(SC)
|
Antineoplastic (Hormone Antagonist)
|
Ferring GMBH
|
Germany
|
Initial (from Monitored Release)
|
27 June 2024
|
29 November 2027
|
| View |
|
DR-XY41308
|
Degarelix
|
Firmagon
|
80 mg
|
Freeze-dried Powder for Solution for Injection
(SC)
|
Antineoplastic (Hormone Antagonist)
|
Ferring GMBH
|
Germany
|
Initial (from Monitored Release)
|
27 June 2024
|
29 November 2027
|
| View |
|
DR-XY41312
|
Midazolam (as hydrochloride)
|
Unbranded
|
1mg/mL
|
Solution for Injection (I.M./I.V.)
|
Hypnotics and Sedatives (Benzodiazepines derivatives)
|
Swiss Parenterals Ltd.
|
India
|
Renewal
|
25 August 2022
|
05 November 2027
|
| View |
|
DR-XY41317
|
Paracetamol
|
Cortalgesic Xtra
|
1g Sustained Release Tablet
|
Tablet
|
NON OPIOD ANALGESIC / ANTIPYRETIC
|
Lincoln Pharmaceuticals Ltd.
|
India
|
Renewal
|
31 May 2022
|
15 October 2027
|
| View |
|
DR-XY41318
|
Phenytoin Sodium
|
None
|
50mg/mL
|
Solution For Injection
|
Antiepileptic (Hydantoin derivative)
|
Hameln Pharmaceuticals GmbH
|
Germany
|
Automatic Renewal
|
10 November 2022
|
18 October 2027
|
| View |
|
DR-XY41323
|
Hydroxyzine Hydrochloride
|
None
|
10 mg
|
Film-Coated Tablet
|
Anxiolytic
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
18 January 2022
|
18 October 2026
|
| View |
|
DR-XY41327
|
Levedopa + Carbidopa
|
Sinedin
|
250 mg/25 mg
|
Tablet
|
Analgesic / Antipyretic / Muscle Relaxant
|
Sydenham Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
08 July 2022
|
20 November 2027
|
| View |
|
DR-XY41332
|
Adenosine
|
Cardiosine
|
3 mg/mL
|
Solution for Injection (IV)
|
Cardiac Therapy (Other Cardiac Preparation)
|
Swiss Parenterals Ltd.
|
India
|
Renewal
|
16 August 2022
|
18 October 2027
|
| View |
|
DR-XY41338
|
5% Dextrose in Lactated Ringer'S
|
None
|
Each 100 mL contains 5 g Dextrose Monohydrate, 600 mg Sodium Chloride, 310 mg Sodium Lactate, Anhydrous, 30 mg Potassium Chloride, 20 mg Calcium Chloride, Dihydrate & 30 mg Sodium Metabisulfite
|
Solution For IV Infusion
|
-
|
Euro-Med Laboratories Phil., Inc.
|
Philippines
|
-
|
29 July 2020
|
30 September 2025
|
| View |
|
DR-XY41342
|
Cholecalciferol
|
Fern D
|
|
Softgel Capsule
|
Vitamin
|
Hizon Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
20 June 2022
|
30 October 2027
|
| View |
|
DR-XY41346
|
Cefixime (as Trihydrate)
|
Umexim-200
|
200 mg
|
Capsule
|
Antibacterial (Cephalosporin)
|
Umedica Laboratories Pvt. Ltd.
|
India
|
Renewal
|
05 August 2022
|
30 October 2027
|
| View |
|
DR-XY41351
|
Trimetazidine Hydrochloride
|
Angivent Od
|
60 mg
|
Sustained-Release Capsule
|
-
|
Inventia Healthcare Limited
|
India
|
Initial (from monitored Release) (Variation)
|
06 June 2023
|
06 June 2028
|
| View |
|
DR-XY41353
|
Iohexol
|
Omnihexol
|
647 mg/mL (equivalent to 300 mg Iodine)
|
Solution For Injection
|
Non-ionic Radiocontrast Media
|
Korea United Pharma. Inc.
|
Korea
|
Initial (Variation)
|
23 June 2022
|
23 October 2027
|